magnifying glass
logo for Exeltis

Exeltis

Manufacturing · New Jersey, United States · 4,000 Employees

Get Full Access

Who is Exeltis

Exeltis is a fast-growing division of Madrid-based Insud Pharma, an integrated health sciences group. It has developed a leading position in the women's healthsector, where it continues to discover, develop, produce and seek new medicines and medical devices to improve the health and wellbeing of women around the world. Exeltis strives to provide care for women throughout their lives. Exeltis offers a broad portfolio of products to respond to patients' needs in Women's Health including contraception, pregnancy, birth, and menopause and has expanded its research in recent years to Central Nervous System (CNS), ophthalmology and endocrinology.Read More

Headquarters

Headquarters:

180 Park Ave, Ste 101, Florham Park, New Jersey, 07932, United States
Phone Number

Phone Number:

(973) 324-0200
Revenue

Revenue:

$763 Million
Exeltis's Social Media
SIC Code 28,283
NAICS Code 44,4461
Popular Searches:

Exeltis USA Inc

Exeltis

Exeltis Pharmaceuticals Holding S.L

Exeltis USA , Inc.

Exeltis USA Dermatology , LLC.

Top Competitors of Exeltis

Employess
600
revenue
$62 Million

1

Employess
22,500
revenue
$5 Billion

2

Employess
5,700
revenue
$2 Billion

3

Employess
4,000
revenue
$758 Million

4

Employess
1,000
revenue
$614 Million

5

Exeltis's Org Chart

Lucas Sigman
Lucas Sigman

Chief Executive Officer

PhonePhoneEmailEmail
Claudia Nohara
Claudia Nohara

Chief Financial Officer

PhonePhoneEmailEmail
Salustiano Perez
Salustiano Perez

President

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Exeltis Company Metrics

Company Insights
Employee Growth Rate
Revenue
QuarterRevenue

'21 - Q1

763380000

'21 - Q2

763380000

Acquisitions & Subsidiaries

Quinnova Pharmaceuticals

See More Acquisitions & Subsidiaries

Exeltis's Tech Stack

Microsoft Excel

By

Microsoft

Ativo

By

Ativo.com

Teamwork

By

Teamwork.com

Tableau

By

Tableau
See more technologies

Exeltis News & Media

Luye Pharma Grants Exeltis Exclusive Commercialization Rights to Its Innovative Alzheimer's Disease Treatment Rivastigmine Multi-Day Transdermal Patch in Mexico and Poland

BASEL, Switzerland, March 31, 2022 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today announced that its subsidiary Luye Pharma Switzerland AG has entered into agreements with Exeltis Pharma México, S.A. de C.V and Exeltis Pharmaceuticals Holding, S.L (Exeltis), under which the company...

Lupin Signs Promotional Agreement with Exeltis on SOLOSEC® (secnidazole) expanding access for Adult Women Suffering with Bacterial Vaginosis and Adults with Trichomoniasis

BALTIMORE, Jan. 27, 2022 /PRNewswire/ -- Lupin Pharmaceuticals Inc., (Lupin), and Exeltis USA Inc. announced a promotional agreement for Exeltis to promote SOLOSEC® along with Exeltis' existing line of Women's Health products, further enhancing value to OBGYNs and their patients. SOLOSEC®...

IntelGenx Announces Market Launch of RIZAPORT® in Spain

SAINT LAURENT, Quebec, Sept. 07, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Exeltis Healthcare S.L. (“Exeltis”), its commercialization partner in the European Union (“EU”) for RIZAPORT®, a unique for the treatment of acute migraines, has launched the product in Spain.
Subscribe to "Exeltis" News

Frequently Asked Questions regarding Exeltis

Where are Exeltis’s headquarters?

Exeltis’s headquarters are in 180 Park Ave, Ste 101, Florham Park, New Jersey, 07932, United States

What is Exeltis’s phone number?

Exeltis’s phone number is (973) 324-0200

What is Exeltis’s official website?

Exeltis’s official website is www.exeltis.com

What is Exeltis’s Revenue?

Exeltis’s revenue is $763 Million

What is Exeltis’s SIC code?

Exeltis’s SIC: 28,283

What is Exeltis’s NAICS code?

Exeltis’s NAICS: 44,4461

How many employees are working in Exeltis?

Exeltis has 4,000 employees

What is Exeltis’s industry?

Exeltis is in the industry of: Manufacturing, Pharmaceuticals, Drug Stores & Pharmacies

Who are Exeltis’s main competitors?

Exeltis's main competitors are: Sprim, Servier, Ipsen Pharma, EMD Serono

What companies has Exeltis acquired?

Exeltis has acquired the companies: Quinnova Pharmaceuticals

What is Exeltis's tech stack?

The technologies that are used by Exeltis are: Microsoft Excel, Ativo, Teamwork, Tableau

Who is Exeltis's CEO?

Exeltis's CEO is Lucas Sigman

Who is Exeltis's CFO?

Exeltis's CFO is Claudia Nohara

See more information about Exeltis
4.4/5 on G2 Crowd